Literature DB >> 3140427

Production and partial characterization of monoclonal antibodies to Bothrops asper (terciopelo) myotoxin.

B Lomonte1, L Kahan.   

Abstract

Seven murine monoclonal antibodies against Bothrops asper myotoxin were produced and partially characterized. They revealed the presence of at least four cross-reacting basic components in crude venom, with a common subunit mol. wt of 16,000 by sodium dodecylsulfate-polyacrylamide gel electrophoresis, but slight differences in charge. These myotoxin-related components might be isoforms of the toxin. By Western blotting and enzyme-immunoassay binding techniques, differences in the reactivities with basic venom fractions were observed among monoclonal antibodies, suggesting differences in epitope specificities. Three antibodies cross-reacted with B. nummifer crude venom. Two monoclonal antibodies were utilized to develop a two-site enzyme-immunoassay for myotoxin detection at the nanogram level. Three of the antibodies (one IgM and two IgG1) showed ability to neutralize myotoxicity of purified myotoxin in preincubation type experiments.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3140427     DOI: 10.1016/0041-0101(88)90249-8

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  7 in total

Review 1.  Pharmacokinetic-pharmacodynamic relationships of immunoglobulin therapy for envenomation.

Authors:  José María Gutiérrez; Guillermo León; Bruno Lomonte
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

2.  Role of enzymatic activity in muscle damage and cytotoxicity induced by Bothrops asper Asp49 phospholipase A2 myotoxins: are there additional effector mechanisms involved?

Authors:  Diana Mora-Obando; Cecilia Díaz; Yamileth Angulo; José María Gutiérrez; Bruno Lomonte
Journal:  PeerJ       Date:  2014-09-16       Impact factor: 2.984

3.  Cross-recognition of a pit viper (Crotalinae) polyspecific antivenom explored through high-density peptide microarray epitope mapping.

Authors:  Mikael Engmark; Bruno Lomonte; José María Gutiérrez; Andreas H Laustsen; Federico De Masi; Mikael R Andersen; Ole Lund
Journal:  PLoS Negl Trop Dis       Date:  2017-07-14

4.  Development of sandwich ELISA and lateral flow strip assays for diagnosing clinically significant snakebite in Taiwan.

Authors:  Chien-Chun Liu; Jau-Song Yu; Po-Jung Wang; Yung-Chin Hsiao; Chien-Hsin Liu; Yen-Chia Chen; Pei-Fang Lai; Chih-Po Hsu; Wen-Chih Fann; Chih-Chuan Lin
Journal:  PLoS Negl Trop Dis       Date:  2018-12-03

5.  Integrating Engineering, Manufacturing, and Regulatory Considerations in the Development of Novel Antivenoms.

Authors:  Andreas Hougaard Laustsen; Netty Dorrestijn
Journal:  Toxins (Basel)       Date:  2018-07-31       Impact factor: 4.546

6.  Structural basis for phospholipase A2-like toxin inhibition by the synthetic compound Varespladib (LY315920).

Authors:  Guilherme H M Salvador; Antoniel A S Gomes; Wendy Bryan-Quirós; Julián Fernández; Matthew R Lewin; José María Gutiérrez; Bruno Lomonte; Marcos R M Fontes
Journal:  Sci Rep       Date:  2019-11-20       Impact factor: 4.379

Review 7.  Antibodies as Snakebite Antivenoms: Past and Future.

Authors:  Wilmar Dias da Silva; Sonia A De Andrade; Ângela Alice Amadeu Megale; Daniel Alexandre De Souza; Osvaldo Augusto Sant'Anna; Fábio Carlos Magnoli; Felipe Raimondi Guidolin; Kemily Stephanie Godoi; Lucas Yuri Saladini; Patrick Jack Spencer; Fernanda Calheta Vieira Portaro
Journal:  Toxins (Basel)       Date:  2022-09-01       Impact factor: 5.075

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.